IDEXX Laboratories Inc (IDXX)

93.72
0.65 0.70
NASDAQ : Health Care
Prev Close 93.07
Open 93.00
Day Low/High 93.00 / 93.83
52 Wk Low/High 63.48 / 95.55
Volume 336.04K
Avg Volume 758.50K
Exchange NASDAQ
Shares Outstanding 89.53M
Market Cap 8.46B
EPS 2.10
P/E Ratio 45.19
Div & Yield N.A. (N.A)

Latest News

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail

Johnson & Johnson was easy, Cramer says, but other stocks were more problematic.

Valeant, Chipotle Both Rise After Sequoia Trades One Troubled Stock For Another

Valeant, Chipotle Both Rise After Sequoia Trades One Troubled Stock For Another

Sequoia Fund has sold its position in Valeant Pharmaceuticals and has added four new positions.

Sequoia Fund Drops Valeant, Allergan and Cabela's

Sequoia Fund Drops Valeant, Allergan and Cabela's

The company once held a 30% stake in Valeant, now owns no Valeant shares.

Box Office Success of 'Secret Life of Pets' Points to Pet Trend, Cramer Says

Box Office Success of 'Secret Life of Pets' Points to Pet Trend, Cramer Says

The humanization of pets trend is one to watch, according to TheStreet's Jim Cramer, reflecting on the box office success of 'The Secret Life of Pets.'

New Lifetime High Reached By IDEXX Laboratories (IDXX)

New Lifetime High Reached By IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

Brazil's Pet Market Shows its Teeth

Brazil's Pet Market Shows its Teeth

Despite some turmoil in Brazil's economy, the country has established itself as one of the fast-growing pet markets in the world. Here's why.

Post-Brexit, a Dog Is an Investor's Best Friend

Post-Brexit, a Dog Is an Investor's Best Friend

When the going gets tough, investors should snuggle up to the stable pet industry.

Jim Cramer's Top Takeaways: Twilio, Idexx Labs

Jim Cramer's Top Takeaways: Twilio, Idexx Labs

Cramer is buying Twilio on any weakness and says Idexx Labs is what you buy after a 'Brexit.'

Jim Cramer's 'Mad Money' Recap: 'Brexit' Is the Dumbest Financial Mistake Ever

Jim Cramer's 'Mad Money' Recap: 'Brexit' Is the Dumbest Financial Mistake Ever

The true cost of British independence from the EU is now becoming apparent, Cramer says.

Don't Miss Today's Strong And Under The Radar Stock: IDEXX Laboratories (IDXX)

Don't Miss Today's Strong And Under The Radar Stock: IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a strong and under the radar candidate

IDEXX Leads The Veterinary Industry With The First Low-Dose Radiography System

IDEXX Leads The Veterinary Industry With The First Low-Dose Radiography System

The ImageVueâ„¢ DR50 Digital Imaging System uses state-of-the-art technology to deliver diagnostic images in real-time at the point of care

IDEXX Launches New Rapid Pregnancy Test For Cattle

IDEXX Launches New Rapid Pregnancy Test For Cattle

21-minute assay improves reproductive performance, enables bovine veterinarians to expand services

New Lifetime High Reached By IDEXX Laboratories (IDXX)

New Lifetime High Reached By IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

Jim Cramer's 'Mad Money' Recap: More Rate Hike Talk, More Market Panic

Jim Cramer's 'Mad Money' Recap: More Rate Hike Talk, More Market Panic

Oil and the Federal Reserve have been running the markets, Cramer says.

Cramer's 'Off the Charts': Pet-Care Stocks Are Investors' Best Friends

Cramer's 'Off the Charts': Pet-Care Stocks Are Investors' Best Friends

Pet-care stocks have weathered market instability in recent months, Bob Lang tells Jim Cramer.

New Lifetime High For IDEXX Laboratories (IDXX)

New Lifetime High For IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

Idexx Laboratories Stock Sees Short Interest Move 17.4% Lower

Idexx Laboratories Stock Sees Short Interest Move 17.4% Lower

The most recent short interest data has been released for the 04/29/2016 settlement date, which shows a 1,174,582 share decrease in total short interest for Idexx Laboratories, Inc. , to 5,569,948, a decrease of 17.42% since 04/15/2016.

IDEXX Labs Looks Set to Climb to $100

Because it was in a $20 consolidation pattern, we should have a decent move.

New Lifetime High Today: IDEXX Laboratories (IDXX)

New Lifetime High Today: IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMZN, CENX, FCN, FITB, FOXF, FSBW, HUN, IDXX, MDU, MITK, NWL, ONB, SWH, TCB, WEX Downgrades: AAL, BKCC, DPZ, DVD, EBMT, GOOD, IDCC, OBAS, SRCL, TLGT Initiations: AM, GLPG Read on to get TheStreet Quant Ratings' detailed report:

Today IDEXX Laboratories (IDXX) Hits New Lifetime High

Today IDEXX Laboratories (IDXX) Hits New Lifetime High

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a new lifetime high candidate

Today's Strong And Under The Radar Stock Is IDEXX Laboratories (IDXX)

Today's Strong And Under The Radar Stock Is IDEXX Laboratories (IDXX)

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a strong and under the radar candidate

IDEXX Laboratories (IDXX) Marked As A Barbarian At The Gate

IDEXX Laboratories (IDXX) Marked As A Barbarian At The Gate

Trade-Ideas LLC identified IDEXX Laboratories (IDXX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate